Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed the stock exchanges about an earnings call scheduled for May 27, 2025 at 8:30 AM IST. The call will cover the company's audited financial results for the fourth quarter and full year ended March 31, 2025. Investors and analysts can join via Zoom after pre-registration, and the earnings presentation will be uploaded to the company's website after the results are announced. The disclosure was made under SEBI's Listing Obligations and Disclosure Requirements Regulations.
This is a routine procedural announcement ahead of the Q4 and FY25 results. It signals upcoming results disclosure but has no direct impact on the stock price; investors should watch for the actual financial results and management commentary on the call.